【结 构 式】 |
【分子编号】26991 【品名】1,3,5-tribromobenzene 【CA登记号】626-39-1 |
【 分 子 式 】C6H3Br3 【 分 子 量 】314.80182 【元素组成】C 22.89% H 0.96% Br 76.15% |
合成路线1
该中间体在本合成路线中的序号:(I)The reaction of 1,3,5-tribromobenzene (I) with 4-fluorobenzaldehyde (II) by means of BuLi in ethyl ether gives the benzhydrol (III), which is condensed with ethyl acrylate (IV) by means of palladium acetate and tri o-tolylphosphine in refluxing acetonitrile yielding the phenylenebisacrylate (V). The acetylation of (V) with acetic anhydride and DMAP in dichloromethane affords the acetate (VI), which is hydrogenated with H2 over Pd/C in ethyl acetate providing the bispropanoate (VII). Selective hydrolysis of (VII) with NaOH in ethanol gives the monoacid (VIII), which is treated with oxalyl chloride in dichloromethane yielding the monoacyl chloride (IX). The reaction of (IX) with NH4OH affords the corresponding amide (X), which is treated with NaOCl and NaOH to perform degradation of the amide group and simultaneous hydrolysis of the ester group providing the amino acid (XI). Finally, this compound is sulfonated with 4-chlorophenylsulfonyl chloride (XII) and NaOH.
【1】 Dack, K.N.; Dickinson, R.P.; Long, C.J.; Steele, J.; Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[((4-chlorophenyl)sulfonyl)amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists. Bioorg Med Chem Lett 1998, 8, 16, 2061. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26991 | 1,3,5-tribromobenzene | 626-39-1 | C6H3Br3 | 详情 | 详情 |
(II) | 12337 | 4-fluorobenzaldehyde | 459-57-4 | C7H5FO | 详情 | 详情 |
(III) | 26992 | (3,5-dibromophenyl)(4-fluorophenyl)methanol | C13H9Br2FO | 详情 | 详情 | |
(IV) | 10164 | ethyl acrylate | 140-88-5 | C5H8O2 | 详情 | 详情 |
(V) | 26993 | ethyl (E)-3-[3-[(E)-3-ethoxy-3-oxo-1-propenyl]-5-[(4-fluorophenyl)(hydroxy)methyl]phenyl]-2-propenoate | C23H23FO5 | 详情 | 详情 | |
(VI) | 26994 | ethyl (E)-3-[3-[(acetoxy)(4-fluorophenyl)methyl]-5-[(E)-3-ethoxy-3-oxo-1-propenyl]phenyl]-2-propenoate | C25H25FO6 | 详情 | 详情 | |
(VII) | 26995 | ethyl 3-[3-(3-ethoxy-3-oxopropyl)-5-(4-fluorobenzyl)phenyl]propanoate | C23H27FO4 | 详情 | 详情 | |
(VIII) | 26996 | 3-[3-(3-ethoxy-3-oxopropyl)-5-(4-fluorobenzyl)phenyl]propionic acid | C21H23FO4 | 详情 | 详情 | |
(IX) | 26997 | ethyl 3-[3-(3-chloro-3-oxopropyl)-5-(4-fluorobenzyl)phenyl]propanoate | C21H22ClFO3 | 详情 | 详情 | |
(X) | 26998 | ethyl 3-[3-(3-amino-3-oxopropyl)-5-(4-fluorobenzyl)phenyl]propanoate | C21H24FNO3 | 详情 | 详情 | |
(XI) | 26999 | 3-[3-(2-aminoethyl)-5-(4-fluorobenzyl)phenyl]propionic acid | C18H20FNO2 | 详情 | 详情 | |
(XII) | 15787 | 4-chlorobenzenesulfonyl chloride;4-chlorobenzene-1-sulfonyl chloride | 98-60-2 | C6H4Cl2O2S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VII)The condensation of 1,3,5-tribromobenzene (VII) with benzaldehyde (VIII) by means of BuLi in ethyl ether gives 3,5-dibromodiphenylmethanol (IX), which is reduced with Tes-H and BF3/Et2O to yield 3,5-dibromodiphenylmethane (X). The carbonylation of (X) with BuLi and DMF in THF affords the benzaldehyde (XI), which is reduced by means of NaBH4 in methanol to provide the benzyl alcohol (XII). The reaction of (XII) with CBr4 and PPh3 in dichloromethane gives the bromomethyl derivative (XIII), which is condensed with 1,3-propanesultam (XIV) by means of K2CO3 in refluxing acetonitrile to yield the adduct (XV). The reaction of (XV) with thalium acetate and palladium acetate in DMF affords the acetyl derivative (XVI), which is brominated with Br2 and AlCl3 in dioxane to provide the bromoacetyl compound (XVII). The condensation of (XVII) with the intermediate amine (VI) by means of TEA in acetonitrile gives the secondary amine (XVIII), which is protected with benzyl chloroformate (XIX) to yield the carbamate (XX). The carboxylation of (XX) by means of CO, EtOH, TEA and PdCl2(PPh3)2 in ethyl acetate affords the pyridine-2-carboxylate derivative (XXI), which is finally cyclized by means of NaOMe in THF to provide the target naphthyridine derivative.
【1】 Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells. J Med Chem 2003, 46, 4, 453. |
【2】 Young, S.D.; Guare, J.P.; Wai, J.S.; Payne, L.S.; Fisher, T.E.; Zhuang, L.; Embrey, M. (Merck & Co., Inc.); Aza- and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors. WO 0236734 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VI) | 61832 | (2-chloro-3-pyridinyl)methanamine; (2-chloro-3-pyridinyl)methylamine | C6H7ClN2 | 详情 | 详情 | |
(VII) | 26991 | 1,3,5-tribromobenzene | 626-39-1 | C6H3Br3 | 详情 | 详情 |
(VIII) | 10498 | Benzaldehyde;Benzoic aldehyde;Phenylmethanal | 100-52-7 | C7H6O | 详情 | 详情 |
(IX) | 61833 | (3,5-dibromophenyl)(phenyl)methanol | C13H10Br2O | 详情 | 详情 | |
(X) | 61834 | 1-benzyl-3,5-dibromobenzene | C13H10Br2 | 详情 | 详情 | |
(XI) | 61835 | 3-benzyl-5-bromobenzaldehyde | C14H11BrO | 详情 | 详情 | |
(XII) | 61836 | (3-benzyl-5-bromophenyl)methanol | C14H13BrO | 详情 | 详情 | |
(XIII) | 61837 | 1-benzyl-3-bromo-5-(bromomethyl)benzene | C14H12Br2 | 详情 | 详情 | |
(XIV) | 61838 | 1lambda~6~-isothiazolidine-1,1-dione | C3H7NO2S | 详情 | 详情 | |
(XV) | 61839 | 2-(3-benzyl-5-bromobenzyl)-1lambda~6~-isothiazolidine-1,1-dione | C17H18BrNO2S | 详情 | 详情 | |
(XVI) | 61840 | 2-(3-acetyl-5-benzylbenzyl)-1lambda~6~-isothiazolidine-1,1-dione | C19H21NO3S | 详情 | 详情 | |
(XVII) | 61841 | 2-[3-benzyl-5-(2-bromoacetyl)benzyl]-1lambda~6~-isothiazolidine-1,1-dione | C19H20BrNO3S | 详情 | 详情 | |
(XVIII) | 61842 | 2-[3-benzyl-5-(2-{[(2-chloro-3-pyridinyl)methyl]amino}acetyl)benzyl]-1lambda~6~-isothiazolidine-1,1-dione | C25H26ClN3O3S | 详情 | 详情 | |
(XIX) | 10101 | Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene | 501-53-1 | C8H7ClO2 | 详情 | 详情 |
(XX) | 61843 | benzyl 2-{3-benzyl-5-[(1,1-dioxo-1lambda~6~-isothiazolidin-2-yl)methyl]phenyl}-2-oxoethyl[(2-chloro-3-pyridinyl)methyl]carbamate | C33H32ClN3O5S | 详情 | 详情 | |
(XXI) | 61844 | ethyl 3-({(2-{3-benzyl-5-[(1,1-dioxo-1lambda~6~-isothiazolidin-2-yl)methyl]phenyl}-2-oxoethyl)[(benzyloxy)carbonyl]amino}methyl)-2-pyridinecarboxylate | C36H37N3O7S | 详情 | 详情 |